HOPE:NASDAQHope Bancorp, Inc. Analysis
Data as of 2026-04-08 - not real-time
$11.88
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hope Bancorp (HOPE) is trading at $11.88, comfortably above its 20‑day ($11.09), 50‑day ($11.58) and 200‑day ($11.04) moving averages, and the MACD shows a bullish crossover (histogram +0.14). The RSI sits at 65, indicating momentum but edging toward overbought territory. Fundamentals reveal a solid 32% revenue growth, a forward PE of 7.6 versus a trailing PE of 24.2, and a dividend yield of 4.71%—though the payout ratio exceeds 100%, raising sustainability concerns. Volatility is elevated at ~25.5% over the past 30 days, while beta (0.89) suggests slightly lower market sensitivity.
The recent acquisition of SMBC ManuBank’s commercial banking unit adds a strategic growth catalyst, yet sector‑wide jitters over private‑credit exposure temper optimism. Analysts project a modest upside of ~15% (target median $14) and a DCF fair value of $33.94, implying the stock is fundamentally undervalued but priced for modest near‑term gains. The dividend’s high yield is attractive, but its sustainability is questionable.
The recent acquisition of SMBC ManuBank’s commercial banking unit adds a strategic growth catalyst, yet sector‑wide jitters over private‑credit exposure temper optimism. Analysts project a modest upside of ~15% (target median $14) and a DCF fair value of $33.94, implying the stock is fundamentally undervalued but priced for modest near‑term gains. The dividend’s high yield is attractive, but its sustainability is questionable.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish technical setup but RSI approaching overbought
- High dividend yield with unsustainable payout
- Elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and forward earnings expansion
- Strategic acquisition of SMBC commercial banking unit
- Undervalued relative to book (P/B 0.67) and DCF fair value
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust cash position versus moderate debt
- Potential to improve dividend sustainability as earnings grow
- Stable beta and US‑centric geographic exposure
Key Metrics & Analysis
Financial Health
Revenue Growth32.00%
Profit Margin13.50%
P/E Ratio24.2
ROE2.79%
ROA0.35%
P/B Ratio0.7
Op. Cash Flow$164.5M
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI65.3
Support$10.51
Resistance$11.91
MA 20$11.09
MA 50$11.58
MA 200$11.04
MACDBullish
VolumeIncreasing
Fear & Greed Index85.25
Valuation
Fair Value$33.94
Target Price$13.63
Upside/Downside14.69%
GradeUndervalued
TypeBlend
Dividend Yield4.71%
Risk Assessment
Beta0.89
Volatility25.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.